Northwestern Medicine scientists have developed a method to identify and characterize microproteins, a development which opens the door for understanding physiology and disease at a molecular level not possible until now, according to findings published in Nature Communications.
Scientists have characterized how non-muscle myosin assembles in cells using the latest advances in technology only available at Northwestern and a handful of institutions worldwide, according to a study published in the Journal of Cell Biology.
Feinberg’s chapter of the Alpha Omega Alpha medical honor society welcomed 40 new members during a ceremony on March 12, recognizing the inductees’ outstanding educational achievement and significant contributions to medicine.
High school juniors from Our Lady of Tepeyac High School in Little Village had the chance to shadow and learn from Feinberg scientists as part of an event hosted by the Simpson Querrey Institute for Epigenetics’ (SQE) Inspire program on March 5.
Northwestern Medicine scientists have identified new genes implicated in the development of uterine fibroids, according to a study published in Nature Communications.
Faculty, residents, trainees and students from Feinberg, the local community and beyond recently came together for Health Equity Week, a week-long series of educational programming designed to expose the roots of healthcare inequities as well as avenues to addressing them.
A mutated protein expressed in lysosomes may contribute to Parkinson’s disease, according to a new Northwestern Medicine study published in the Journal of Cell Biology.
A type of white blood cell is responsible for growth and branching of blood vessels which supports tumor growth in colon cancer, according to a Northwestern Medicine study published in the Journal of Clinical Investigation.
An experimental drug may provide a new treatment option for some patients with rare incurable brain tumors, according to an analysis published in the Journal of Clinical Oncology.
Specific immunosuppressants and immunotherapy are not enough to prevent organ rejection in patients undergoing skin cancer treatment who have also received a kidney transplant, according to a clinical trial published in the Journal of Clinical Oncology.